KINTOR PHARMA's mid-term loss expands to 83.27 million RMB

AASTOCKS
2025.08.28 15:58

KINTOR PHARMA-B (09939.HK) announced its interim results for the six months ending in June, with revenue recorded at RMB 5.98 million. The loss widened from RMB 71.49 million in the same period last year to RMB 83.27 million, with a loss per share of 19 cents. No dividend is declared

Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer